<DOC>
	<DOCNO>NCT01611844</DOCNO>
	<brief_summary>The test available vivo diagnosis tuberculosis intradermal injection tuberculin accord Mantoux method ( also name tuberculosis skin test PPD skin test ) . The tuberculin skin test base delayed-type hypersensitivity skin reaction However , test need perform trained personnel , present problem reproducibility , interpretation well standardize ( measure millimeter skin induration 48 72 hour PPD skin test ) . The new generation BD micro needle use study solve technical difficulty ; intradermal administration tuberculin could make personnel . A non-invasive objective instrumental method read test also test .</brief_summary>
	<brief_title>Optimization Tuberculosis Intradermal Skin Test</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>Subject age 18 year Tuberculosis skin test ( PPD ) positive : 5mm = &lt; PPD &lt; 15mm ( 24 subject ) negative : PPD &lt; 5mm ( 6 subject ) Negative Quantiferon test . Legal capacity consent Subject give write consent participation Subject accept participate second phase study skin biopsy ( 24 subject positive PPD ) Females childbearing potential use effective method contraception , least 1 month begin study 1 month end participation Known allergy tuberculin History severe skin reaction tuberculin vesicle , ulceration , necrosis History active tuberculosis Latent tuberculosis ( positive Quantiferon test ) Contact person active tuberculosis previous 3 month Chronic disease nonstabilized treatment Immunosuppressive therapy corticosteroid within 1 month PPD skin test Nonsteroid antiinflammatory drug within 1 week PPD skin test Application study area topical drug contain corticoid immunosuppressant within 1 week PPD skin test Dermatological disease study area Known allergy local anesthetic Wound heal disorder Subject exclusion period participate plan participate another biomedical research</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>delayed-type hypersensitivity reaction tuberculin intradermal injection</keyword>
	<keyword>tuberculosis skin test</keyword>
	<keyword>BD micro-needle</keyword>
	<keyword>medical device</keyword>
	<keyword>spectroscopy</keyword>
</DOC>